Vivos Expands Insurance Coverage for Sleep Apnea Treatment, Targets Profitability

Vivos Therapeutics (NASDAQ: VVOS) is expanding patient access to its sleep apnea treatments as supported physician practices in Nevada gain in-network status with major insurers and Medicare. This move could significantly increase access to care for patients with obstructive sleep apnea, opening the door to the company’s non-invasive, FDA-cleared solutions.

Alongside expanding coverage, Vivos is implementing cost reduction initiatives expected to save approximately $4 million annually, positioning the company for improved financial performance. With a large underserved global market, Vivos is aiming to drive growth and move toward positive cash flow by 2026.

#VivosTherapeutics
#VVOS
#SleepApnea
#HealthcareInnovation
#MedicalDevices
#InsuranceCoverage
#Medicare
#DigitalHealth
#PatientCare
#Biotech
#HealthcareAccess
#Wellness
#MedicalTechnology
#AnnaBerry
#NewsOut